Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Aegon NV ADR (AEG)

NYSE
Currency in USD
Disclaimer
6.115
-0.075(-1.21%)
Closed
Pre Market
6.180+0.065(+1.06%)

AEG Comments

Vaccin pfizer, break out Aegon.
to buy tommorow for intraday please ?
  November 9th was the day Pfizer announced vaccin and Aegon broke out to higher levels.
 I assumed you already were in this stock, intraday is always hard to say, that's a descission you have to make yourself.
Is genrating a buy ....
Dear Mr. Dirk_P about AEG do you think is it worth to entry before earnings to hold and after earnings to sell ? what is your opinion please ? Best Regards., Jack from Texas USA.
  In my opinion yes, buy on weakness. Important date for Aegon is dec 10th 2020, the new CEO Lard Friese will then unfold Aegons new strategie on Aegons investorday. Number H2 2020 not due until januari 2021. Stock is severely undervalued right now.
Is generating a buy the last weeks. Resistance broken ....
i would have invested but I see they have not paid in 6 months-interval last payment is written August 2019
would like to move $50,000 into this and see where it goes
hello Mr. Lucas., my name is Konstantinos and I am a money manager . Did you invested your 50k in this share finally ? what experience did you got please ?
knew someone that worked at this company for a while. should be a penny stock
please what was your experience finally?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.